Myopia Is a Disease: Why the AMA’s New Position Matters for Parents
Myopia Is More Than Blurry Distance Vision
For generations, childhood myopia was often handled in a very simple way: a child became more nearsighted, the prescription was increased, and a new pair of glasses restored clear distance vision. The problem is that clear vision does not necessarily mean the underlying myopia has stopped progressing.
That distinction is becoming harder to ignore. In September 2026, the American Medical Association adopted a resolution supporting formal classification of myopia as a disease, including recognition by the Centers for Medicare and Medicaid Services. The resolution also supports better childhood vision screening, public education, and insurance coverage for appropriate pediatric myopia treatment.
For parents, the message is important: myopia deserves to be treated as a progressive health condition, not simply as a yearly prescription change.
Why the AMA Action Matters
Myopia is extremely common and becoming more common. The American Academy of Ophthalmology announcement cited by Ophthalmology Times notes that myopia affects roughly 41.6% of the U.S. population and that prevalence has risen substantially over the past several decades.
The health concern is not simply inconvenience. As myopia becomes more severe, the lifetime risk of retinal detachment, glaucoma, cataracts, and myopic maculopathy increases. These conditions can threaten permanent vision. Recognizing myopia as a disease helps shift attention from correcting today’s blur to reducing tomorrow’s risk.
The AMA resolution also matters because many families still pay out of pocket for myopia management. Insurance coverage remains inconsistent. Formal disease recognition can help support the case that slowing childhood myopia progression is legitimate medical care rather than an optional upgrade.
Early Detection Creates More Opportunity to Act
Myopia often begins during the school years and can continue progressing while the eyes are still growing. Children who become nearsighted at younger ages may have more years for progression to occur. That is one reason early detection matters.
Parents should pay attention to signs such as squinting to see far away, sitting closer to the television, difficulty seeing the board at school, or repeated increases in a glasses prescription. A family history of myopia can also raise a child’s risk.
Once myopia is identified, the next question should be more than “What prescription does my child need?” Parents should also ask whether the myopia is progressing, how the doctor will monitor eye growth, and whether myopia-control treatment is appropriate.
Treatment Options Have Changed
Families now have multiple evidence-based options designed to slow myopia progression. Depending on the child, these may include specially designed myopia-control spectacle lenses, multifocal soft contact lenses, orthokeratology, or low-dose atropine. The best treatment depends on the child’s age, prescription, eye growth, activities, maturity, and family preferences.
The AMA action is timely because treatment choices have advanced significantly. Myopia-management care is no longer limited to watching the prescription worsen and replacing glasses year after year.
Lifestyle also matters. Outdoor time is associated with a lower risk of myopia onset, and families should continue encouraging children to spend time outside. But once a child has progressive myopia, healthy habits should complement—not replace—clinical evaluation and treatment.
Myopia Management Is Different From Routine Vision Correction
Traditional glasses correct blurry vision. Myopia management is designed to do something more: slow the progression of nearsightedness while the child’s eyes are still developing.
That requires measurement and follow-up. In addition to checking visual acuity and prescription, a myopia-focused evaluation may include axial length measurement, review of prescription history and family history, assessment of lifestyle and other risk factors, and ongoing monitoring to determine whether treatment is working.
How Treehouse Eyes Approaches Childhood Myopia
Treehouse Eyes practices focus specifically on myopia management for children. Our doctors use the Treehouse Vision System, a clinical protocol designed to evaluate a child’s risk, choose an individualized treatment plan, and monitor progression over time.
The goal is not simply to prescribe a product. It is to manage a changing condition. If treatment is not producing the desired response, the doctor can use follow-up measurements to decide whether the plan should be adjusted.
This approach reflects the same principle behind the AMA’s new position: myopia should be taken seriously as a disease that deserves active management.
What Parents Can Do Now
If your child is already nearsighted, ask whether the prescription has changed over the past year and whether the doctor is monitoring progression. If your child has never been evaluated for myopia control, ask what options may be appropriate.
If your child is not yet nearsighted but has one or two myopic parents, spends significant time doing close-up work, or shows signs of distance blur, early assessment can help identify risk before a stronger prescription becomes the annual routine.
Parents can also encourage regular outdoor time, healthy breaks from prolonged close work, and routine comprehensive eye examinations throughout the school years.
Questions to Ask at Your Child’s Next Eye Exam
- If your child has myopia, consider asking:
- Is my child’s myopia progressing?
- Are you measuring axial length or otherwise tracking eye growth?
- What myopia-management treatments are appropriate for my child?
- How will we know whether treatment is working?
- How often should my child be monitored?
A comprehensive conversation about these questions is very different from simply increasing the glasses prescription and waiting another year.
The AMA’s decision to support formal classification of myopia as a disease is an important step because it reflects how childhood myopia should increasingly be understood: as a progressive condition with meaningful long-term eye-health consequences.
For parents, that means earlier detection, closer monitoring, and asking about evidence-based treatment when a child’s myopia is progressing. Clear vision today matters. Protecting long-term vision matters too.
If your child is nearsighted or their prescription keeps getting stronger, schedule a comprehensive myopia evaluation with a Treehouse Eyes practice and learn what options are available.
Schedule a comprehensive myopia evaluation with a Treehouse Eyes practice, or take the FREE Myopia Risk Assessment at https://treehouseeyes.com/risk-assessment-form/.

